Skip to Main Content

Third Rock Ventures is launching a new cancer diagnostics company called Thrive Sciences, according to a new corporation registration filed in Massachusetts last month.

The documents are vague about the new company’s specific targets. But the long list of directors listed on the form — many of whom have substantial expertise in liquid biopsy work — send a strong signal that Thrive will be working around that technology.


Liquid biopsy companies typically work on ways to screen blood for signs of a disease like cancer. Often, the technique is touted as a potential way to catch cancer earlier and improve a person’s chances of survival.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.